Literature DB >> 7769485

Involvement of the renin-angiotensin system in the development of left ventricular hypertrophy and dysfunction.

T Yamazaki1, I Shiojima, I Komuro, R Nagai, Y Yazaki.   

Abstract

OBJECTIVES: To elucidate the regulation of cardiac gene expression by mechanical stress and to analyse molecular mechanisms associated with the involvement of angiotensin II (Ang II) in the development of cardiac hypertrophy and dysfunction.
METHODS: Neonatal rat cardiocytes were cultured in deformable silicone dishes, and mechanical stress was imposed on the cardiocytes by stretching them. In in vivo studies, spontaneously hypertensive rats (SHR) were treated with a non-peptide, specific Ang II type 1 receptor antagonist, TCV 116.
RESULTS: Expression of c-fos was rapidly induced, and fetal type genes such as skeletal alpha actin and beta myosin heavy chain genes were re-expressed by stretching. The mechanical stress decreased the expression of Ca(2+)-ATPase in the sarcoplasmic reticulum. With regard to signals for the development of cardiac hypertrophy, mechanical stress evoked c-fos expression via the activation of protein kinase C. The phosphorylation cascade (sequential activation of protein kinase C, Raf-1 kinase, mitogen-activated protein kinase kinase, mitogen-activated protein kinase and S6 kinase), which may be involved in protein synthesis and gene expression, was activated by mechanical stress in cardiocytes. Stretch-induced cardiac cellular hypertrophy was partially inhibited by TCV 116. TCV 116 treatment of SHR reduced left ventricular weight, left ventricular wall thickness, myocyte transverse diameter, V3 myosin heavy chain levels and the interstitial collagen volume fraction.
CONCLUSIONS: These results indicate that Ang II may, in part, mediate the stretch-induced hypertrophic growth of cardiomyocytes via the type 1 Ang II receptor.

Entities:  

Mesh:

Year:  1994        PMID: 7769485

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  6 in total

1.  Long-term safety and efficacy of renin-angiotensin blockade in atherosclerotic renal artery stenosis.

Authors:  Sofia Sofroniadou; Theodoros Kassimatis; Rajaventhan Srirajaskanthan; John Reidy; David Goldsmith
Journal:  Int Urol Nephrol       Date:  2011-11-30       Impact factor: 2.370

Review 2.  Clinical practice. Renal-artery stenosis.

Authors:  Lance D Dworkin; Christopher J Cooper
Journal:  N Engl J Med       Date:  2009-11-12       Impact factor: 91.245

3.  Impact of AT2 receptor deficiency on postnatal cardiovascular development.

Authors:  Daniel Biermann; Andreas Heilmann; Michael Didié; Saskia Schlossarek; Azadeh Wahab; Michael Grimm; Maria Römer; Hermann Reichenspurner; Karim R Sultan; Anna Steenpass; Süleyman Ergün; Sonia Donzelli; Lucie Carrier; Heimo Ehmke; Wolfram H Zimmermann; Lutz Hein; Rainer H Böger; Ralf A Benndorf
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240

4.  Renin angiotensin system and cardiac hypertrophy after sinoaortic denervation in rats.

Authors:  Aline Cristina Piratello; Ivana Moraes-Silva; Janaina Paulini; Pamella Ramona Souza; Raquel Sirvente; Vera Salemi; Karin Flues; Edson Dias Moreira; Cristiano Mostarda; Tatiana Cunha; Dulce Elena Casarini; Maria Claudia Irigoyen
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

5.  The role of mAKAPβ in the process of cardiomyocyte hypertrophy induced by angiotensin II.

Authors:  Huixin Guo; Baoxin Liu; Lei Hou; Erlinda The; Gang Li; Dongzhi Wang; Qiqiang Jie; Wenliang Che; Yidong Wei
Journal:  Int J Mol Med       Date:  2015-03-02       Impact factor: 4.101

6.  Pioglitazone Protected against Cardiac Hypertrophy via Inhibiting AKT/GSK3β and MAPK Signaling Pathways.

Authors:  Wen-Ying Wei; Zhen-Guo Ma; Si-Chi Xu; Ning Zhang; Qi-Zhu Tang
Journal:  PPAR Res       Date:  2016-03-27       Impact factor: 4.964

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.